Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
New myeloma treatment regimen shows good results. |
EurekAlert: The researchers, led by Andrzej J. Jakubowiak, M.D., Ph.D., professor of medicine and director of the multiple myeloma program at the University of Chicago Medical Center, found that combining carfilzomib, a next generation proteasome inhibitor, with two standard drugs – lenalidomide and low-dose dexamethasone compared favorably to other frontline regimens. |